[Diagnosis and management of central nervous system infections in pediatric cancer patients]

Klin Padiatr. 2005 Nov:217 Suppl 1:S120-9. doi: 10.1055/s-2005-872506.
[Article in German]

Abstract

Infections of the central nervous system (CNS) are a common cause of neurological abnormalities in pediatric oncology patients apart from cancer disease of the CNS. Often symptoms do not present unequivocally, impeding a clear distinction from other differential diagnosis. Repeated neurological examinations of the patient allow selecting the necessary laboratory tests and imaging techniques. As delayed antiinfectious treatment is associated with high mortality and severe sequelae of survivors, patients do need empirical therapy using adequate doses until diagnostic results allow a more specific treatment. This article provides the recommendations of the Infectious Diseases Working Party of the German Society for Pediatric Infectious Diseases (DGPI) and the German Society for Pediatric Hematology/Oncology (GPOH) for diagnosis and treatment of infections of the CNS in immunocompromised patients.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Anti-Infective Agents / adverse effects
  • Anti-Infective Agents / therapeutic use
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Central Nervous System Infections / diagnosis*
  • Central Nervous System Infections / drug therapy
  • Central Nervous System Infections / etiology
  • Child
  • Combined Modality Therapy / adverse effects
  • Diagnosis, Differential
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / radiotherapy
  • Neurologic Examination
  • Neutropenia / chemically induced*
  • Neutropenia / complications
  • Opportunistic Infections / diagnosis*
  • Opportunistic Infections / drug therapy
  • Opportunistic Infections / etiology
  • Prognosis

Substances

  • Anti-Infective Agents
  • Antineoplastic Agents